MiaMed Overview
- Status
-
Acquired/Merged
- Latest Deal Type
-
M&A
- Financing Rounds
-
1
MiaMed General Information
Description
Developer of brain disorder medicines. The company provides research and development services for cyclin-dependent kinase-like 5 focused on treatment of brain disorders.
Contact Information
Ownership Status
Acquired/Merged
Financing Status
Corporate Backed or Acquired
Primary Office
- 641 Lexington Avenue
- 15th Floor
- New York, NY 10022
- United States
MiaMed Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
MiaMed Executive Team (1)
| Name | Title | Board Seat | Contact Info |
|---|---|---|---|
| Michael Jasulavic | Chief Executive Officer & President |